News
Optibrium has launched StarDrop 8, the latest update to its molecular design platform. The new version integrates real-time collaboration across the compound design and optimisation workflow, helping teams make faster decisions and move efficiently from hit to candidate.
StarDrop 8 provides an all-in-one solution for medicinal chemists, combining interactive data visualisation, structure-activity relationship analysis, compound design tools, and in silico modelling. Collaboration is built directly into the platform, allowing teams to work seamlessly without switching between tools.
The platform helps scientists turn complex discovery data into actionable insights, enabling teams to prioritise compounds with the greatest potential and focus synthesis efforts where they matter most. Real-time sharing prevents duplicated work and improves decision-making.
StarDrop 8 also centralises project data in a secure, shared environment accessible from any location. Users can explore and visualise data their way while instantly sharing results with colleagues, boosting productivity and supporting reproducibility.
Edmund Champness, Chief Scientific Officer at Optibrium, said: “StarDrop 8 helps teams stay aligned and make faster, smarter decisions throughout the discovery process.”
The update strengthens predictive capabilities with new ADME models and molecular property calculators, helping chemists select and optimise compounds more confidently.
More information online
ILM Guide 2026/27